Keywords: tarceva, gets, chmp, ok, pancreatic, cancer, swiss

Tarceva gets CHMP OK for pancreatic cancer

Article | 22 December 2006

Print This

Swiss drug major Roche says that its drug Tarceva (erlotinib) has received a positive approval recommendation from the European Medicines ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in